Main > ONCOLOGY (**) > Breast Cancer>HER2+>MET *** > Treatment > UK. M. BioSimilar TrastuzuMAb

---

UK. M. BioSimilar TrastuzuMAb's subsections
(*) USA Approval Date: 2017. 12.01
Company
TradeMark

UK. M. BioSimilar TrastuzuMAb's products
This section has no products